I know that some patents on the device have expired. However, there still seems to be frequent reference to Mylan's current eligibility for patent protection. H

I know that some patents on the device have expired. However, there still seems to be frequent reference to Mylan's current eligibility for patent protection. Here's one such reference from a New York Times editorial, published today [0]: >Today that same tiny, lifesaving bolus of epinephrine — used mostly to treat severe allergic reactions — is delivered via sometimes elaborate devices called auto-injectors. Though the medicine itself hasn’t changed, the delivery devices have been protected by patents, enabling drug makers to charge ever escalating — sometimes prohibitive — prices for one of the oldest drugs in medical use. It doesn't say which patents specifically may cover the EpiPen, but as far as I can tell, the consensus is that the device is patent protected. I would love to know if there's definitive evidence either way -- specifically which patents Mylan claims to be protected under, or whether this is in reality just a common assumption/myth. [0] http://www.nytimes.com/2016/09/04/opinion/sunday/the-lesson-of-epipens-why-drug-prices-spike-again-and-again.html http://www.nytimes.com/2016/09/04/opinion/sunday/the-lesson-...